Explainable Artificial Intelligence for Patient Safety: A Review of Application in Pharmacovigilance

S Lee, S Kim, J Lee, JY Kim, MH Song, S Lee - IEEE Access, 2023 - ieeexplore.ieee.org
Explainable AI (XAI) is a methodology that complements the black box of artificial
intelligence, and its necessity has recently been highlighted in various fields. The purpose of …

The use of artificial intelligence in pharmacovigilance: a systematic review of the literature

M Salas, J Petracek, P Yalamanchili, O Aimer… - Pharmaceutical …, 2022 - Springer
Introduction Artificial intelligence through machine learning uses algorithms and prior
learnings to make predictions. Recently, there has been interest to include more artificial …

Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review

B Kompa, JB Hakim, A Palepu, KG Kompa, M Smith… - Drug Safety, 2023 - Springer
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review,
written by Benjamin Kompa, Joe B. Hakim, Anil Palepu, Kathryn Grace Kompa, Michael …

Artificial intelligence in pharmacovigilance: scoping points to consider

M Hauben, CG Hartford - Clinical Therapeutics, 2021 - Elsevier
Artificial intelligence (AI), a highly interdisciplinary science, is an increasing presence in
pharmacovigilance (PV). A better understanding of the scope of artificial intelligence in …

Artificial intelligence in pharmacovigilance–Opportunities and challenges

MK Desai - Perspectives in Clinical Research, 2024 - journals.lww.com
Pharmacovigilance (PV) is a data-driven process to identify medicine safety issues at the
earliest by processing suspected adverse event (AE) reports and extraction of health data …

[引用][C] Artificial intelligence in pharmacovigilance: Do we need explainability?

M Hauben - Pharmacoepidemiology and Drug Safety, 2022 - Wiley Online Library
Artificial intelligence, especially machine learning models (herein also referred to as
“machines”), increasingly make important automated decisions (eg, classifying, predicting …

[PDF][PDF] Artificial intelligence in pharmacovigilance: a regulatory perspective on explainability

LC Pinheiro, X Kurz - Pharmacoepidemiol Drug Saf, 2022 - researchgate.net
Artificial intelligence (AI) holds the promise of boosting efficiency of processes and
increasing insights into data across all aspects of life, including healthcare, such as for …

[HTML][HTML] On the road to explainable AI in drug-drug interactions prediction: A systematic review

TH Vo, NTK Nguyen, QH Kha, NQK Le - Computational and Structural …, 2022 - Elsevier
Over the past decade, polypharmacy instances have been common in multi-diseases
treatment. However, unwanted drug-drug interactions (DDIs) that might cause unexpected …

Explainable artificial intelligence for pharmacovigilance: What features are important when predicting adverse outcomes?

IR Ward, L Wang, J Lu, M Bennamoun… - Computer Methods and …, 2021 - Elsevier
Abstract Background and Objective. Explainable Artificial Intelligence (XAI) has been
identified as a viable method for determining the importance of features when making …

“Artificial intelligence” for pharmacovigilance: ready for prime time?

R Ball, G Dal Pan - Drug safety, 2022 - Springer
There is great interest in the application of 'artificial intelligence'(AI) to pharmacovigilance
(PV). Although US FDA is broadly exploring the use of AI for PV, we focus on the application …